Amphastar pharmaceuticals reports financial results for the three months ended march 31, 2022

Reports net revenues of $120.4 million for the three months ended march 31, 2022 rancho cucamonga, ca / accesswire / may 9, 2022 / amphastar pharmaceuticals, inc. (nasdaq:amph) ("amphastar" or the "company") today reported results for the three months ended march 31, 2022. first quarter highlights net revenues of $120.4 million for the first quarter gaap net income of $24.3 million, or $0.47 per share, for the first quarter adjusted non-gaap net income of $24.6 million, or $0.47 per share, for the first quarter dr. jack zhang, amphastar's president and chief executive officer, commented: "the first quarter continued where 2021 ended, with strong sales of our recently launched products, which confirms our strategy focused on complex products with commercial strength.
AMPH Ratings Summary
AMPH Quant Ranking